Sen. Tina Smith Presses Swiss Pharmaceutical Giant Novartis to Ensure Improper Company Actions Aren't Pushing Up U.S. Prescription Drug Prices
August 24, 2018
August 24, 2018
WASHINGTON, Aug. 24 -- The office of Sen. Tina Flint Smith, D-Minnesota, issued the following news release:
Today, U.S. Sen. Tina Smith (D-Minn.) pushed for answers from Swiss pharmaceutical giant Novartis on improper financial and lobbying efforts - including a $1.2 million dollar payment to President Trump's former lawyer Michael Cohen - that could be contributing to high prescription drug prices for people in Minnesota and across the country.
In May, Novartis co . . .
Today, U.S. Sen. Tina Smith (D-Minn.) pushed for answers from Swiss pharmaceutical giant Novartis on improper financial and lobbying efforts - including a $1.2 million dollar payment to President Trump's former lawyer Michael Cohen - that could be contributing to high prescription drug prices for people in Minnesota and across the country.
In May, Novartis co . . .